These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
352 related items for PubMed ID: 9685210
1. In vitro interaction between STAT 5 and JAK 2; dependence upon phosphorylation status of STAT 5 and JAK 2. Flores-Morales A, Pircher TJ, Silvennoinen O, Gustafsson JA, Sanchez-Gomez M, Norstedt G, Haldosén LA, Wood TJ. Mol Cell Endocrinol; 1998 Mar 16; 138(1-2):1-10. PubMed ID: 9685210 [Abstract] [Full Text] [Related]
2. Phosphorylation and activation of the DNA binding activity of purified Stat1 by the Janus protein-tyrosine kinases and the epidermal growth factor receptor. Quelle FW, Thierfelder W, Witthuhn BA, Tang B, Cohen S, Ihle JN. J Biol Chem; 1995 Sep 01; 270(35):20775-80. PubMed ID: 7657660 [Abstract] [Full Text] [Related]
3. Tyrosyl phosphorylation and DNA binding activity of signal transducers and activators of transcription (STAT) proteins in hematopoietic cell lines transformed by Bcr/Abl. Carlesso N, Frank DA, Griffin JD. J Exp Med; 1996 Mar 01; 183(3):811-20. PubMed ID: 8642285 [Abstract] [Full Text] [Related]
4. Desensitization of the growth hormone-induced Janus kinase 2 (Jak 2)/signal transducer and activator of transcription 5 (Stat5)-signaling pathway requires protein synthesis and phospholipase C. Fernández L, Flores-Morales A, Lahuna O, Sliva D, Norstedt G, Haldosén LA, Mode A, Gustafsson JA. Endocrinology; 1998 Apr 01; 139(4):1815-24. PubMed ID: 9528967 [Abstract] [Full Text] [Related]
5. Dissociation of Janus kinase 2 and signal transducer and activator of transcription 5 activation after treatment of Nb2 cells with a molecular mimic of phosphorylated prolactin. Coss D, Kuo CB, Yang L, Ingleton P, Luben R, Walker AM. Endocrinology; 1999 Nov 01; 140(11):5087-94. PubMed ID: 10537136 [Abstract] [Full Text] [Related]
6. An alternative pathway for STAT activation that is mediated by the direct interaction between JAK and STAT. Fujitani Y, Hibi M, Fukada T, Takahashi-Tezuka M, Yoshida H, Yamaguchi T, Sugiyama K, Yamanaka Y, Nakajima K, Hirano T. Oncogene; 1997 Feb 20; 14(7):751-61. PubMed ID: 9047382 [Abstract] [Full Text] [Related]
7. In vitro activation of Stat3 by epidermal growth factor receptor kinase. Park OK, Schaefer TS, Nathans D. Proc Natl Acad Sci U S A; 1996 Nov 26; 93(24):13704-8. PubMed ID: 8942998 [Abstract] [Full Text] [Related]
8. The functional role of the JAK-STAT pathway in post-infarction remodeling. El-Adawi H, Deng L, Tramontano A, Smith S, Mascareno E, Ganguly K, Castillo R, El-Sherif N. Cardiovasc Res; 2003 Jan 26; 57(1):129-38. PubMed ID: 12504822 [Abstract] [Full Text] [Related]
9. Specific DNA binding and transactivation potential of recombinant, purified Stat5. Beisenherz-Huss C, Mundt M, Herrala A, Vihko P, Schubert A, Groner B. Mol Cell Endocrinol; 2001 Oct 25; 183(1-2):101-12. PubMed ID: 11604230 [Abstract] [Full Text] [Related]
10. Activation of Stat3 in v-Src-transformed fibroblasts requires cooperation of Jak1 kinase activity. Zhang Y, Turkson J, Carter-Su C, Smithgall T, Levitzki A, Kraker A, Krolewski JJ, Medveczky P, Jove R. J Biol Chem; 2000 Aug 11; 275(32):24935-44. PubMed ID: 10823829 [Abstract] [Full Text] [Related]
11. Peripheral but not central axotomy induces changes in Janus kinases (JAK) and signal transducers and activators of transcription (STAT). Schwaiger FW, Hager G, Schmitt AB, Horvat A, Hager G, Streif R, Spitzer C, Gamal S, Breuer S, Brook GA, Nacimiento W, Kreutzberg GW. Eur J Neurosci; 2000 Apr 11; 12(4):1165-76. PubMed ID: 10762348 [Abstract] [Full Text] [Related]
12. Interleukin-3-induced activation of the JAK/STAT pathway is prolonged by proteasome inhibitors. Callus BA, Mathey-Prevot B. Blood; 1998 May 01; 91(9):3182-92. PubMed ID: 9558373 [Abstract] [Full Text] [Related]
13. Specificity of transcription enhancement via the STAT responsive element in the serine protease inhibitor 2.1 promoter. Wood TJ, Sliva D, Lobie PE, Goullieux F, Mui AL, Groner B, Norstedt G, Haldosén LA. Mol Cell Endocrinol; 1997 Jun 20; 130(1-2):69-81. PubMed ID: 9220023 [Abstract] [Full Text] [Related]
14. The thrombopoietin receptor c-MPL activates JAK2 and TYK2 tyrosine kinases. Sattler M, Durstin MA, Frank DA, Okuda K, Kaushansky K, Salgia R, Griffin JD. Exp Hematol; 1995 Aug 20; 23(9):1040-8. PubMed ID: 7543416 [Abstract] [Full Text] [Related]
15. Regulation of the trans-activation potential of STAT5 through its DNA-binding activity and interactions with heterologous transcription factors. Groner B, Fritsche M, Stöcklin E, Berchtold S, Merkle C, Moriggl R, Pfitzner E. Growth Horm IGF Res; 2000 Apr 20; 10 Suppl B():S15-20. PubMed ID: 10984248 [Abstract] [Full Text] [Related]
16. Dual mechanism of signal transducer and activator of transcription 5 activation by the insulin receptor. Le MN, Kohanski RA, Wang LH, Sadowski HB. Mol Endocrinol; 2002 Dec 20; 16(12):2764-79. PubMed ID: 12456798 [Abstract] [Full Text] [Related]
17. Angiotensin II blockade prevents hyperglycemia-induced activation of JAK and STAT proteins in diabetic rat kidney glomeruli. Banes AK, Shaw S, Jenkins J, Redd H, Amiri F, Pollock DM, Marrero MB. Am J Physiol Renal Physiol; 2004 Apr 20; 286(4):F653-9. PubMed ID: 14678947 [Abstract] [Full Text] [Related]
18. Regulation of signal transducer and activator of transcription (STAT) 5b activation by the temporal pattern of growth hormone stimulation. Gebert CA, Park SH, Waxman DJ. Mol Endocrinol; 1997 Apr 20; 11(4):400-14. PubMed ID: 9092792 [Abstract] [Full Text] [Related]
19. Growth hormone stimulates tyrosine phosphorylation of JAK2 and STAT5, but not insulin receptor substrate-1 or SHC proteins in liver and skeletal muscle of normal rats in vivo. Chow JC, Ling PR, Qu Z, Laviola L, Ciccarone A, Bistrian BR, Smith RJ. Endocrinology; 1996 Jul 20; 137(7):2880-6. PubMed ID: 8770909 [Abstract] [Full Text] [Related]
20. Thrombopoietin (TPO) induces tyrosine phosphorylation and activation of STAT5 and STAT3. Bacon CM, Tortolani PJ, Shimosaka A, Rees RC, Longo DL, O'Shea JJ. FEBS Lett; 1995 Aug 14; 370(1-2):63-8. PubMed ID: 7544303 [Abstract] [Full Text] [Related] Page: [Next] [New Search]